P
PSYG
vs
S
S&P TSX Composite Index (Canada)
Over the past 12 months, PSYG has significantly outperformed S&P TSX Composite Index (Canada), delivering a return of +700% compared to the S&P TSX Composite Index (Canada)'s +33% growth.
Stocks Performance
PSYG vs S&P TSX Composite Index (Canada)
Performance Gap
PSYG vs S&P TSX Composite Index (Canada)
Performance By Year
PSYG vs S&P TSX Composite Index (Canada)
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Psyence Group Inc
Glance View
Psyence Group, Inc. is a science-led global psychedelic platform, led by experts in neurology, neuroscience and drug development. The company is headquartered in Toronto, Ontario. The company went IPO on 2021-01-27. The firm builds and operates commercial psilocybin cultivation and production facilities. The company offers natural psilocybin for the long-term treatment of psychological trauma and its mental health consequences. The Company’s natural psychedelics are cultivated in Lesotho. The company focuses on the scientific research and development of psilocybin medical products for research institutions, clinics and regulatory-compliant psilocybin. The company operates across Toronto, Canada; Washington District of Columbia (DC), United States of America; Cape Town, South Africa; Kolojane, Kingdom of Lesotho; Kingston, Jamaica; London United Kingdom; Sydney, Australia and Sao Paulo, Brazil.
